Background illustration for clinical trials search

Paid Clinical Trials Meridian

Discover 224 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Boise ID, Los Angeles CA, Orange CA, Rochester MN,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT07154706

Phase 3, Recruiting

E-Mindfulness Approaches for Living After Breast Cancer

for
Breast Cancer, Depression
Location: Boise ID, Redmond OR, Bend OR, Hood River OR,
Sponsor: NRG Oncology

Sex: All

Age: 18 - 50

Code: NCT06748222

Phase 3, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boise ID, Spokane WA, Issaquah WA, Seattle WA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase 3, Recruiting

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Boise ID, Ogden UT, Reno NV, Seattle WA, Billings MT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06997497

Phase 3, Recruiting

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Boise ID, Salt Lake City UT, Springfield OR,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT03907046

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Boise ID, Portland OR, Seattle WA, San Francisco CA,
Sponsor: Edwards Lifesciences

Sex: All

Age: 65+

Code: NCT04889872

Recruiting

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

for
Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis
Location: Boise ID, Clackamas OR, New Westminster, Vancouver,
Sponsor: University of British Columbia

Sex: All

Age: 0+

Code: NCT04634240

Recruiting

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for
Crohn's Disease
Location: Boise ID, Ogden UT, Tacoma WA, Seattle WA,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase 2, Recruiting

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

for
Chronic Inducible Urticaria, Cold Urticaria,
Location: Boise ID, Sandy City UT, Redwood City CA,
Sponsor: Celldex Therapeutics

Sex: All

Age: 18+

Code: NCT07266402

Phase 3, Recruiting

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

for
Crohn's Disease, Ulcerative Colitis
Location: Boise ID, Vancouver WA, Tacoma WA, Bellevue WA,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07697456

Phase 2, Recruiting

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: Boise ID, Idaho Falls ID, Spokane WA, Portland OR,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07415044

Phase 2, Recruiting

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

for
Chronic Idiopathic Constipation (CIC)
Location: Boise ID, Blackfoot ID, Ogden UT, Salt Lake City UT,
Sponsor: Ardelyx

Sex: All

Age: 18 - 70+

Code: NCT07382167

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for
NonSegmental Vitiligo
Location: Boise ID, Missoula MT, Spokane WA, Murray UT,
Sponsor: Incyte Corporation

Sex: All

Age: 2 - 11

Code: NCT06548360

Phase 3, Recruiting

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

for
Acute Respiratory Distress Syndrome, ARDS
Location: Boise ID, Salt Lake City UT, Portland OR, Davis CA,
Sponsor: Direct Biologics, LLC

Sex: All

Age: 18 - 70+

Code: NCT05354141

Phase 3, Recruiting

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

for
COVID-19 SARS-CoV-2 Infection
Location: Boise ID, Butte MT, Clinton UT, Redding CA, Vancouver,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT06679140

Phase 3, Recruiting

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

for
COVID-19 Infection
Location: Boise ID, Seattle WA, Sacramento CA, Aurora CO,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07013474

Phase 3, Recruiting

Study of ALTO-300 in MDD

for
Major Depressive Disorder
Location: Boise ID, Mather CA, Lafayette CA, Las Vegas NV,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70

Code: NCT05922878

Phase 2, Recruiting

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

for
Focal Onset Seizures
Location: Boise ID, Portland OR, Los Angeles CA, Orange CA,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT05716100

Phase 3, Recruiting

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

for
Focal Epilepsy, Epilepsy, Refractory Focal Epilepsy, Seizure,
Location: Boise ID, Rochester MN, Houston TX, Nashville TN,
Sponsor: Rapport Therapeutics Inc.

Sex: All

Age: 18 - 70

Code: NCT07219407

Phase 2, Recruiting

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

for
Primary Generalized Tonic-Clonic Seizures
Location: Boise ID, Seattle WA, Lethbridge, Vancouver,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 12+

Code: NCT05667142

Phase 3, Recruiting